Home The study of ischemia modified albumin as an early biomarker of epilepsy in adolescent population: a cross-sectional study
Article
Licensed
Unlicensed Requires Authentication

The study of ischemia modified albumin as an early biomarker of epilepsy in adolescent population: a cross-sectional study

  • Priyanka Asia , Anuj Sharma , Ashok Kumar Ahirwar EMAIL logo , Seema Garg , Jyoti Elgiva John and Niranjan Gopal
Published/Copyright: February 4, 2021

Abstract

Objectives

Epilepsy is one of the most common neurological disorders, diagnosis of which is challenging as many unrelated conditions may mimic seizure. Epilepsy impairs the quality of life of patients due to associated physical and psychological trauma. Epileptic patients are also at increased risk of premature death due to autonomic disturbance and fatal accidents. The aim of the present research work was to study ischemia modified albumin (IMA) as an early biomarker of epilepsy in the adolescent population.

Methods

Twenty-five diagnosed cases of epilepsy and 25 healthy volunteers as control of adolescent group were recruited as study subjects. The study subjects were age and sex matched. Clinical evaluation, routine biochemical parameters and IMA estimation were carried out. Serum IMA was measured by spectrophotometric method.

Results

The mean serum IMA levels were significantly raised in epileptic patients (0.69 ± 0.1 absorbance units [ABSU]) as compared to the healthy control group (0.52 ± 0.24 ABSU) (p=0.004). ROC curve of IMA predicted that at cut off of 0.59 ABSU, the IMA has 96% sensitivity and 52% specificity for diagnosing epilepsy.

Conclusions

IMA may be used as a biomarker for early diagnosis of epilepsy as well as to differentiate epileptic seizure from various non epileptic disorders in the adolescent population.


Corresponding author: Dr. Ashok Kumar Ahirwar, MD, Assistant Professor, Department of Biochemistry, All India Institute of Medical Sciences, Nagpur, Maharashtra441108, India, Phone: +919654210832, E-mail:

Award Identifier / Grant number: STS ICMR Project 2019- 20

Acknowledgments

We are very thankful to Dr. Y. V. Bansod from Department of Medicine and Dr. Dipty Jain from Department of Pediatrics, GMC, Nagpur, MH for their contribution in the recruitment of the study population.

  1. Research funding: Funded by the Indian Council of Medical Research (STS ICMR Project 2019–20).

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Conflict of interest: Authors state no conflict of interest.

  4. Informed consent: Informed written consent was taken from the patients/parents/guardian.

  5. Ethical approval: The study was conducted in accordance with the Declaration of Helsinki and approved by Institutional Ethical Committee of AIIMS, Nagpur, MH.

References

1. Stafstrom, CE, Carmant, L. Seizures and epilepsy: an overview for neuroscientists. Cold Spring Harbor Perspect Med 2015:5:022426. https://doi.org/10.1101/cshperspect.a022426.Search in Google Scholar

2. Meyer, AC, Dua, T, Ma, J, Saxena, S, Birbeck, G. Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Organ 2010;88:260–6. https://doi.org/10.2471/blt.09.064147.Search in Google Scholar

3. Amudhan, S, Gururaj, G, Satishchandra, P. Epilepsy in India I: epidemiology and public health. Ann Indian Acad Neurol 2015;18:263. https://doi.org/10.4103/0972-2327.160093.Search in Google Scholar

4. Santhosh, NS, Sinha, S, Satishchandra, P. Epilepsy: Indian perspective. Ann Indian Acad Neurol 2014;17(Suppl 1):S3. https://doi.org/10.4103/0972-2327.128643.Search in Google Scholar

5. Shin, HW, Jewells, V, Hadar, E, Fisher, T, Hinn, A. Review of epilepsy-etiology, diagnostic evaluation and treatment. Int J Neurorehabilitation 2014;1:2376–0281.Search in Google Scholar

6. Bhalla, D, Godet, B, Druet-Cabanac, M, Preux, PM. Etiologies of epilepsy: a comprehensive review. Exp Rev Neurother 2011;11:861–76. https://doi.org/10.1586/ern.11.51.Search in Google Scholar

7. Yin, YH, Ahmad, N, Makmor-Bakry, M. Pathogenesis of epilepsy: challenges in animal models. Iran J Basic Med Sci 2013;16:1119.Search in Google Scholar

8. Gaze, DC. Ischemia modified albumin: a novel biomarker for the detection of cardiac ischemia. Drug Metab Pharmacokinet 2009;24:333–41. https://doi.org/10.2133/dmpk.24.333.Search in Google Scholar

9. Onis, MD, Onyango, AW, Borghi, E, Siyam, A, Nishida, C, Siekmann, J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 2007;85:660–7. https://doi.org/10.2471/blt.07.043497.Search in Google Scholar

10. Kamasak, T, Turedi, S, Serin, HM, Mentese, A, Gündüz, A, Alver, A, et al.. Can ischemia-modified albumin be used to differentiate between generalized seizures and pseudoseizures? Turk J Med Sci 2017;47:282–6.10.3906/sag-1504-105Search in Google Scholar

11. Bar–Or, D, Lau, E, Winkler, JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia—a preliminary report. J Emerg Med 2000;19:311–5.10.1016/S0736-4679(00)00255-9Search in Google Scholar

12. Uzel, M, Oray, NC, Bayram, B, Kume, T, Girgin, MC, Doylan, O, et al.. Novel biochemical marker for differential diagnosis of seizure: ischemia-modified albumin. Am J Emerg Med 2014;32:962–5. https://doi.org/10.1016/j.ajem.2014.05.003.Search in Google Scholar PubMed

13. Kobylarek, D, Iwanowski, P, Lewandowska, Z, Limphaibool, N, Szafranek, S, Labrzycka, A, et al.. Advances in the potential biomarkers of epilepsy. Front Neurol 2019:10.10.3389/fneur.2019.00685Search in Google Scholar

14. Ristić, AJ, Savić, D, Sokić, D, Bogdanović Pristov, J, Nestorov, J, Baščarević, V, et al.. Hippocampal antioxidative system in mesial temporal lobe epilepsy. Epilepsia 2015;56:789–99.10.1111/epi.12981Search in Google Scholar

15. Gaze, DC. Ischemia modified albumin: a novel biomarker for the detection of cardiac ischemia. Drug Metabol Pharmacokine 2009;24:333–41. https://doi.org/10.2133/dmpk.24.333.Search in Google Scholar

16. Bar–Or, D, Lau, E, Winkler, JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia—a preliminary report 1. J Emerg Med 2000;19:311–5.10.1016/S0736-4679(00)00255-9Search in Google Scholar

17. Abboud, H, Labreuche, J, Meseguer, E, Lavallee, PC, Simon, O, Olivot, JM, et al.. Ischemia-modified albumin in acute stroke. Cerebrovasc Dis 2007;23:216–20. https://doi.org/10.1159/000097644.Search in Google Scholar PubMed

18. Kocaoglu, C, Caksen, H, Atabek, ME, Kurku, H, Arslan, S. Serum ischemia-modified albumin levels in children with epileptic seizures. Pediatr Emerg Care 2014.10.1097/PEC.0000000000000145Search in Google Scholar PubMed

19. Inci, A, Gencpinar, P, Orhan, D, Uzun, G, Ozdem, S, Samur, AA, et al.. Ischemia-modified albumin levels in children having seizure. Brain and Development 2013;35:849. https://doi.org/10.1016/j.braindev.2012.11.004.Search in Google Scholar PubMed

Received: 2020-09-03
Accepted: 2021-01-17
Published Online: 2021-02-04

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Special Section: "Progestogen-only pill and its therapeutic indications and effects"; Guest Editors: Adolf E- Schindler and René Druckmann
  3. Original Articles
  4. Peritoneal fluid biomarkers in patients with endometriosis: a cross-sectional study
  5. Safety, influence on the endometrium, sonographic changes and bleeding profile after 13 cycles with the new drospirenone only pill (DOP) for contraception
  6. Review Articles
  7. A progestin isn’t a progestin: dienogest for endometriosis as a blueprint for future research – Review as a contribution for discussion -
  8. Progestogens in luteal support
  9. Mini Review
  10. Progestogen-only pills: which progestogen would be ideal
  11. Regular Issue
  12. Original Articles
  13. Outcomes of surgical and/or medical treatment in patients with prolactinomas during long-term follow-up: a retrospective single-centre study
  14. PPARGC1A promoter DNA-methylation level and glucose metabolism in Ecuadorian women with Turner syndrome
  15. Allium jesdianum hydro alcoholic extract ameliorates diabetic nephropathy by suppressing connective tissue growth factor (CTGF) and receptor for advanced glycation endproducts (RAGE) gene expression in diabetic rats with streptozotocin
  16. Changes in serum levels of Apo AIV in patients with newly diagnosed hyperthyroidism and hypothyroidism: a preliminary study
  17. The study of ischemia modified albumin as an early biomarker of epilepsy in adolescent population: a cross-sectional study
  18. Short Communications
  19. The effect of water-based rhythmic exercise training on glucose homeostasis and thyroid hormones in postmenopausal women with metabolic syndrome
  20. Evaluation of glutathione reductase activity in colon tissue of patients with irritable bowel syndrome
  21. Case Report
  22. A rare association of two endocrine tumours: non-functional oncocytic adrenocortical carcinoma and Papillary thyroid carcinoma
  23. Mini Review
  24. Vitamin D and new insights into pathophysiology of type 2 diabetes
  25. Review Articles
  26. Sex steroids-induced neurogenesis in adult brain: a better look at mechanisms and mediators
  27. Genetic variants and risk of thyroid cancer among Iranian patients
Downloaded on 18.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/hmbci-2020-0060/html
Scroll to top button